The aim of this multicentre randomised double blind study was to compare the efficacy and safety of the 200-300 mg sustained release diltiazem formulation administered once daily (200-300 SR) with standard diltiazem (D) given three or four times daily to patients with stable angina. Patients aged 59
Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: Double-blind and open-label studies
✍ Scribed by Roger Messin; Fabienne Carreer-Bruhwyler; Claude Dubois; Jean-Pierre Famaey; Joseph Géczy
- Publisher
- Springer Healthcare Communications
- Year
- 2006
- Tongue
- English
- Weight
- 336 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0741-238X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the safety and tolerability of three different dosing schedules of memantine in patients with moderate to severe Alzheimer's disease (AD). ## Method This 12‐week, randomised, double‐blind study, investigated three dosing schedules of memantine: OD1 (20 mg once
## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr
This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients with severe, chronic plaque-type psoriasis. Patients were randomized on a 1:1 basis to 24 weeks of treatment with Neoral (n = 152) or Sandimmun (n = 157). The starting dose